BioIVT Expands its Biospecimen Portfolio in Support of Neuroscience Research

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today introduced its new Center for NeuroExcellence. This endeavor was made possible by the acquisition of PrecisionMed, a prominent supplier of high-quality human biological material for neurology drug discovery, biomarker research, and in vitro diagnostics, earlier this year.

Through its Center for NeuroExcellence, BioIVT offers neurology researchers a single-vendor solution for obtaining everything from controls to difficult-to-collect biofluid samples from populations with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).

Extensive Resources

BioIVT manages the largest private global repository of longitudinally collected human cerebrospinal fluid (CSF) samples. Its collection contains more than 170,000 samples of banked CSF with matched biomaterials from living normal control and diseased populations.

This neuro-related repository also includes TruNormal® biological control samples collected from donors with normal cognition and no neurological complaint or personal or family history.

All the company’s biospecimens are quality controlled, ethically procured under an institutional review board-approved protocol, and delivered with detailed clinical data, such as the donor’s diagnosis, demographics, family medical histories, treatment responses, and disease progression.

BioIVT experts will be available to answer questions in booth #1004 at Neuroscience 2023, which will be held from November 11-15 at the Walter E. Washington Convention Center in Washington, D.C.

About BioIVT

BioIVT enables smarter science and accelerates medical breakthroughs by delivering high-quality personalized biospecimen solutions and research services to the life science and diagnostic industries. We specialize in control and disease state samples including human and animal tissues or preparations, ADME-Tox products and research services, cell and gene therapy products, blood, and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®. For more information, please visit www.bioivt.com or follow the company on Twitter @BioIVT.